I remain bullish on Palantir due to its strong revenue growth, operational success, and expanding moat, despite high valuation metrics. Risks include declining billings and reliance on interest ...
Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.
We recently compiled a list of the Jim Cramer Highlighted Buying Opportunities in 13 Stocks. In this article, we are going to ...
While being the most expensive SaaS business in the market, there's a plausible narrative that Palantir may be fairly valued at a mere 30% revenue CAGR. Q4 2024 results give confidence to prior ...
Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Palantir shares hit a new record last week after reporting a strong 2025 outlook and ...
Shares of Palantir Technologies Inc. (NYSE: PLTR) got a big boost on Monday, rallying by 5.31%. This continues momentum that began last Monday ahead of its Q4 2024 earnings call, when the ...
Palantir is helping companies achieve tangible savings, and it should be set for another year of strong growth. When you're providing a product that delivers tangible savings to organizations ...
Shares of Palantir Technologies soared over the past week on strong earnings and guidance, just as Elon Musk's DOGE embarked on an aggressive campaign to upend government workforce and spending ...
Palantir shares are trading at new all-time highs on Thursday. Palantir reported financial results for the fourth quarter this week that exceeded analyst expectations. Get real-time earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results